IL1B and periodontitis: Elevated levels of these mediators are present in gingival tissue and/or gingival crevicular fluid from periodontitis patients, correlating with disease severity (5, 36, 37), and studies in animal models show that genetic ablation or pharmacological targeting of IL-6 or IL-1β ameliorates pathology in experimental periodontitis (38).